透過您的圖書館登入
IP:18.217.228.35
  • 學位論文

以侖道假體與自研數學假體評估鼻咽癌病人在動態弧形調控放射治療下的輻射劑量分布

Evaluating Dose Distributions for Nasopharyngeal Carcinoma Based on Rando and SDM Phantoms undergoing VMAT

指導教授 : 陳健懿

摘要


一般的治療計畫,當鼻咽癌病人以亞瑟刀進行動態弧形調控放射治療時,不會考慮到其產生的大量二次輻射。若將二次輻射納入評估,更可增進準確評估健康風險之能力。本研究使用了Rando假體、SDM假體,並使用以直線加速器在6MV光子下,進行熱發光劑量計TLD-100H之校正。校正後TLD置入假體內的器官組織,量測後使用ICRP 103號告之標稱危險度評估罹患致死二次癌症之風險。Rando假體與SDM假體的有效劑量分別為7.11±0.61 mSv與5.66±0.63 mSv。並討論以回歸分析法,以腫瘤為中心於不同距離下,構成之指數函數。經計算TLD-100H之最小可測值為8.08nC。這些結果可望提供關於防輻射工作者,患者,家屬和公眾實際方向。

並列摘要


Routine treatment planning does not consider the secondary radiation resulting from radiotherapy exposure for nasopharyngeal carcinoma patients undergoing Volumetric modulated arc therapy of Axesse (Elekta 2538) linear accelerator, and the peripheral doses. However, such treatment is potentially important for improved accuracy of estimated health risks. Effective dose (E) and nominal risks were evaluated using Alderson Rando phantom and self-developed mathematic phantoms. Thermoluminescent dosimeters (TLD-100H) were calibrated using LINAC 6 MV photons. These TLDs were inserted into phantom positions that closely approximated organs or tissues. The risks of incurring fatal secondary malignancies were estimated by ICRP 103. E of Rando phantom was 7.11±0.61 mSv as well as SDM is 5.66±0.63 mSv, respectively. Fitting exponential functions to this trend created the relationships of the radiation dose with tumor center and regression analysis (R2) were also discussion. The minimum detectable limit (MDL) using this approach was estimated to be 8.08 nC. The quantitative results could provide practical guidance regarding radiation protection to workers, patients, the relatives and the public.

參考文獻


陳芯鈺,2014,於VMAT治療計畫下,肺癌患者之正常器官劑量評估。碩士論文,中山醫學大學生物醫學科學研究所。
洪于婷,2013,評估體重差異下的假體在腹部CT掃描下的有效劑量。碩士論文,中山醫學大學生物醫學科學研究所。
葉俞伶、朱欣怡、蔡筱涵、陳健懿、劉文山,2011,螺旋光子刀對不同體重之肺癌患者的散射劑量及危險度評估。C. J. Radiol. Tech. 2011; 35(2), 104-110.
陳昌震、邱志宏、詹幸敏、粘爲元、朱健豪,2009,LiF: Mg, Cu, P 熱發光劑量計能量依持性與角度依持性研究。台灣應用輻射與同位素雜誌, 5(2):637-644.
鄒宗龍 、范君凱 、許芳裕 、蔡孟融 、彭學恭,2008,TLD-100及TLD-100H熱發光劑量計之消光特性分析。台灣應用輻射與同位素雜誌, 4(2):481-488.

被引用紀錄


黃瀚生(2015)。評估侖道假體在亞瑟刀直線加速器照射鼻咽癌下的治療室環境劑量〔碩士論文,中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2015.00120
林弘智(2015)。利用128電腦斷層掃描於假體頭部進行三種不同檢查偵測的有效劑量〔碩士論文,中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2015.00083
廖鴻霖(2017)。評估以TomoEDGE進行鼻咽癌治療計劃之劑量分佈〔碩士論文,中山醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0003-0901201720492900

延伸閱讀